Answers are grounded in this paper and cite their sources.
Background Masseter ultrasonographic characteristics remain incompletely described in antidepressant users with differing clinical bruxism classifications. This study compared three predefined clinical groups. Methods This single-center cross-sectional study used prospectively acquired clinical and imaging data from 123 adults: antidepressant users with clinically defined probable bruxism and a self-reported temporal association (G1, n = 42), antidepressant users without probable bruxism (G2, n = 31), and non-antidepressant controls without probable bruxism (G3, n = 50). For G1, recalled onset or worsening of bruxism-related complaints after treatment initiation was recorded during anamnesis; this chronology was entirely retrospective. Bilateral thickness, estimated volume, and a reciprocal strain-elastography metric were measured at rest and during voluntary clenching; fractal dimension was calculated from resting images. Nonparametric comparisons, adjusted regression models, and secondary inter-parameter correlations were performed. Results G1 had higher resting and clenching thickness, estimated volume, reciprocal strain-elastography values, and resting fractal dimension than G2 and G3. Thickness, estimated volume, and the reciprocal strain-elastography metric increased from rest to clench in all groups. Between-group differences remained statistically evident in models adjusted for the measured covariates. Conclusions Masseter ultrasound-derived measurements differed among the predefined clinical groups. These findings do not establish the onset or progression of bruxism, a causal effect of antidepressant use, or a medication-specific muscle phenotype.
No takes yet. Share an insight, caveat, or question.
Tekın et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: